Pharmaceutical News

RSS

Pharmacist cautions against self-medicating with ozempic for dementia risk reduction

“According to the latest figures released by the NHS, dementia diagnosis is at a record high in England.

29 Jul 2024

GLP-1-based polyagonists: A promising weight loss alternative to bariatric surgery

Researchers highlight the unprecedented success of GLP-1-based multi-receptor drugs in achieving substantial weight loss and improved health outcomes, potentially replacing bariatric surgery for obesity treatment.

28 Jul 2024

Experimental cancer drug may help clear HIV from infected cells in the brain

An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new Tulane University study.

25 Jul 2024

Study finds flurbiprofen ester effective for pain relief during transvaginal 4D hysterosalpingography

Announcing a new article publication for BIO Integration journal. The purpose of this study was to determine the analgesic effect of a flurbiprofen ester injection via continuous intravenous drip during transvaginal 4-dimensional hysterosalpingography (TVS 4D-HyCoSy).

25 Jul 2024

Experimental cancer drug could make thinking easier for individuals with Rett syndrome

An experimental cancer drug could make thinking easier for individuals with Rett syndrome, a rare disorder linked to autism, according to new research from the University of California San Diego - a discovery that could lead to therapies for patients with other neurological conditions.

25 Jul 2024

Study confirms esaxerenone as a safe and effective alternative for hypertension treatment

Researchers find that esaxerenone is a non-inferior alternative to trichlormethiazide for treating uncontrolled hypertension in Japanese patients. The study confirms similar safety profiles for both drugs.

25 Jul 2024

Opioid use disorder medications underused after injection-related infections

Deaths from injection-related infections like endocarditis have increased among young people, likely due to the growth of injection drug use and stronger, shorter-acting fentanyl.

24 Jul 2024

High-risk NSAID prescriptions cost NHS £31 million

Prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to people at high risk of harm from them is estimated to cost the NHS in England around £31 million and cause more than 6,000 lost years of good health over 10 years, finds a study published by The BMJ today.

24 Jul 2024

Older adults show interest in deprescribing, study reveals

More than 82% of Americans age 50 to 80 take one or more kinds of prescription medication, and 80% of them say they'd be open to stopping one or more of those drugs if their health care provider gave the green light, a new University of Michigan study shows.

24 Jul 2024

World-famous wall drug isn’t immune from challenges facing rural pharmacies

Stacey Schulz parks in a rear lot to avoid the crowded Main Street entrances to her local pharmacy.

24 Jul 2024

Louisiana reclassifies drugs used in abortions as controlled dangerous substances

Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state's list of controlled dangerous substances, a move that has alarmed doctors in the state.

24 Jul 2024

Study warns of medication expiry risk for Mars-bound astronauts

Medications used by astronauts on the International Space Station might not be good enough for a three-year journey to Mars.

23 Jul 2024

Why millions are trying FDA-authorized alternatives to big pharma’s weight loss drugs

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself "at my ideal body weight," with his cholesterol below 200 for the first time in 20 years. "I feel fantastic," he said.

23 Jul 2024

Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.

23 Jul 2024

COVID vaccines and infections in early pregnancy show no increased risk of birth defects in large Nordic study

Research on 343,066 infants across Denmark, Sweden, and Norway shows no increased risk of congenital anomalies from COVID-19 infections or vaccinations during the first trimester. The study confirms safety, supporting vaccination recommendations for pregnant women.

22 Jul 2024

Study identifies trends in the use of glucagon-like peptide-1 receptor agonists

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) - prescription medications sold under popular drug names like Ozempic and Wegovy - in the United States.

22 Jul 2024

Understanding the role of structural racism in newborn drug testing practices

Previous
1
...
45
46
47
48
49
50
51
...
1467
Next

Pharmaceutical News

Pharmacist cautions against self-medicating with ozempic for dementia risk reduction

GLP-1-based polyagonists: A promising weight loss alternative to bariatric surgery

Experimental cancer drug may help clear HIV from infected cells in the brain

Study finds flurbiprofen ester effective for pain relief during transvaginal 4D hysterosalpingography

Experimental cancer drug could make thinking easier for individuals with Rett syndrome

Study confirms esaxerenone as a safe and effective alternative for hypertension treatment

Opioid use disorder medications underused after injection-related infections

High-risk NSAID prescriptions cost NHS £31 million

Older adults show interest in deprescribing, study reveals

World-famous wall drug isn’t immune from challenges facing rural pharmacies

Louisiana reclassifies drugs used in abortions as controlled dangerous substances

Study warns of medication expiry risk for Mars-bound astronauts

Why millions are trying FDA-authorized alternatives to big pharma’s weight loss drugs

Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

COVID vaccines and infections in early pregnancy show no increased risk of birth defects in large Nordic study

Study identifies trends in the use of glucagon-like peptide-1 receptor agonists

Understanding the role of structural racism in newborn drug testing practices

Efficacy and safety of nirmatrelvir/ritonavir in treating COVID-19: A systematic review

Combination therapy incorporating three existing drugs shows potential for treating retinal degenerations

Breakthrough malaria vaccines RTS,S and R21 poised to save thousands of lives

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News